Blend - Regenerative Research
Wolverine Stack
$110.00
+ $15.00 flat tracked shipping · Australia wide
Flat-rate tracked shipping of $15 AUD applies to every order, anywhere in Australia. Vials ship in insulated, discreet, unbranded packaging with tracking supplied on dispatch.
Wolverine Stack combines BPC-157 (10 mg) and TB-500 (10 mg) in a 20 mg lyophilised research blend. Both peptides are investigated in preclinical research involving cellular signalling, tissue repair mechanisms and regenerative biological pathways.
- Presentation
- Lyophilised powder
- Quantity
- 20 mg (BPC-157 10 mg / TB-500 10 mg)
- Purity
- 99%
- Category
- Blend - Regenerative Research
- Availability
- In stock
Sold strictly as a laboratory reference material for in-vitro research. Not for human or veterinary use. Purchasers must be 18+.
Product description
Wolverine Stack is a dual-peptide research blend containing BPC-157 (10 mg) and TB-500 (10 mg), providing a combined total of 20 mg of lyophilised material. BPC-157 is a synthetic pentadecapeptide investigated for its involvement in tissue repair mechanisms, angiogenesis, inflammatory signalling and gastrointestinal tissue responses. TB-500 is associated with research into thymosin beta-4-related biological pathways, including cellular migration, actin regulation and tissue remodelling. Research findings depend on the specific TB-500 sequence used. Together, these compounds provide a research formulation for investigating distinct biological signalling pathways associated with cellular repair and regeneration. For laboratory research purposes only. Not intended for human or veterinary administration.
Research context
Preclinical research involving BPC-157 has examined fibroblast activity, vascular signalling, inflammatory responses and connective tissue models. Thymosin beta-4-related research has investigated cellular migration, actin regulation and tissue remodelling. Findings involving full-length thymosin beta-4 may not apply to shorter TB-500 fragments. Research into the combined formulation remains limited. No established human dosing protocol or clinical efficacy has been demonstrated.
Handling & disclaimer
All products supplied by Pepper Labs are sold strictly as laboratory reference materials for in-vitro research and analytical use only. They are not medicines, not food, not cosmetics and not for human or veterinary consumption. Nothing on this website is medical advice, and no therapeutic claim is made or implied. Pepper Labs does not publish dosing schedules, administration guidance or protocols of any kind. Researchers are responsible for compliance with all applicable Australian laws and institutional requirements.
Storage
Store the sealed lyophilised vial refrigerated at 2–8°C where supported by manufacturer stability data. Protect from direct light and moisture. Once reconstituted, keep refrigerated at 2–8°C if supported by formulation-specific stability data. The usable storage period depends on the diluent, preparation conditions and validated stability information.
Reconstitution notes
For laboratory preparation, slowly introduce a validated compatible diluent down the inner wall of the vial. Swirl gently until fully dissolved. Do not shake vigorously. For a 20 mg vial containing BPC-157 10 mg and TB-500 10 mg, a final solution volume of 2 mL produces a nominal concentration of 5 mg/mL of each peptide (10 mg/mL combined). Confirm diluent compatibility and solution stability before laboratory use.
Documentation
A certificate of analysis for the current lot is available on request. Message us on WhatsApp with the product name and we will send the analytical package.